Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma

NCT03267888 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

ISS Stage I Plasma Cell Myeloma
ISS Stage II Plasma Cell Myeloma
ISS Stage III Plasma Cell Myeloma
Recurrent Plasma Cell Myeloma
Refractory Plasma Cell Myeloma

Interventions

BIOLOGICAL: Pembrolizumab
RADIATION: Radiation Therapy

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]